When it comes to brain cancer treatments, I cannot help but feel as though there is risk associated with the ones which are used today. There are only a common few which are implemented the most and they seem to have their own positives in addition to negatives. From what I continue to read about this condition, though, it appears that we're slowly seeing more in the way of advancements. There is one new finding which may prove to be, in comparison to current methods, less toxic.
With more than one method able to be utilized, I would say that a number of them are negatively impactful to the brain in great amounts. Whole-brain therapy, for example, can ultimately harm a patient, even though it is designed to help. The problem is that the toxic component of this is tremendously high, which means that the brain cells can be impacted. In addition, the nervous system itself could be compromised, making it potentially more harmful than any form of cancer associated with it.
An article on Bioscience Technology reported on a new system, potentially able to help those with cancer. CNS lymphoma is regarded as a somewhat uncommon type of cancer but this therapy could sprout results for more brain cancer treatments to come about. This system is in phase 2 and a study has been done with the help of 44 patients. Based on how much attention has been given to this story by organizations the likes of Voices Against Brain Cancer, it's not one to ignore.
This type of therapy would be implemented, patients being granted high-dose chemotherapy in tandem with immune therapy. This is uncommon, seeing as how said patients were previously given chemo with whole-brain therapy, which was talked about before. The article said that the change elicited great results, saying that patients had follow-ups of around five years or so. This condition is typically seen in people sixty years or age or over but it's still a bit of information can help just about anyone associated with it.
I am of the opinion that treatments, in terms of brain cancer as well as other conditions, can come about and help everyone as opposed to just a select group of people. Researchers have to understand what makes these conditions work, though. They also have to be able to look at the brain and see how it operates so that certain drugs and therapies can be altered in order to help it. I believe that these kinds of trials can be done and, more importantly, become ones that can sprout finer results.
With more than one method able to be utilized, I would say that a number of them are negatively impactful to the brain in great amounts. Whole-brain therapy, for example, can ultimately harm a patient, even though it is designed to help. The problem is that the toxic component of this is tremendously high, which means that the brain cells can be impacted. In addition, the nervous system itself could be compromised, making it potentially more harmful than any form of cancer associated with it.
An article on Bioscience Technology reported on a new system, potentially able to help those with cancer. CNS lymphoma is regarded as a somewhat uncommon type of cancer but this therapy could sprout results for more brain cancer treatments to come about. This system is in phase 2 and a study has been done with the help of 44 patients. Based on how much attention has been given to this story by organizations the likes of Voices Against Brain Cancer, it's not one to ignore.
This type of therapy would be implemented, patients being granted high-dose chemotherapy in tandem with immune therapy. This is uncommon, seeing as how said patients were previously given chemo with whole-brain therapy, which was talked about before. The article said that the change elicited great results, saying that patients had follow-ups of around five years or so. This condition is typically seen in people sixty years or age or over but it's still a bit of information can help just about anyone associated with it.
I am of the opinion that treatments, in terms of brain cancer as well as other conditions, can come about and help everyone as opposed to just a select group of people. Researchers have to understand what makes these conditions work, though. They also have to be able to look at the brain and see how it operates so that certain drugs and therapies can be altered in order to help it. I believe that these kinds of trials can be done and, more importantly, become ones that can sprout finer results.
About the Author:
Contact Voices Against Brain Cancer if you're searching for more information about brain cancer treatments.